Skip to content

CHouse.UKCHouse.UK

Search companies Features Pricing About Contact

Sign in Start free

Search companies Features Pricing About Contact Sign in

SPERO CANTAB UK LIMITED

Company no. 10175336 · Private limited company · Incorporated 11 May 2016

Overview Directors and officers Filings Ownership and control Charges (secured lending)

CHouse.UKCHouse.UK

Company monitoring and filing deadlines for UK practices. CHouse.UK is independent of Companies House.

Support · [email protected]

General & legal · [email protected]

Product

Search companies
Features
Pricing
Sign in

Company

About
Contact
Support
Help centre
Feedback

Legal

Terms and Conditions
Privacy Policy

[email protected][email protected]

CHouse.UK is independent of Companies House and is not endorsed by the UK government. Contains public sector information licensed under the Open Government Licence v3.0.

© 2026 CHouse.UK

Made for UK practices.

Sign in Start free

Cookie preferences

Choose the optional tools you allow. Necessary storage stays on. Your saved choice changes only when you select an action below.

Necessary

Always on

Sign-in, security and remembering your choice. Required to provide the services you request.

Analytics

Measures visits, journeys, referrals and feature use so we can improve CHouse.UK.

Experience insights

Heatmaps and session recordings help us understand clicks, scrolling and usability. Recordings can include content visible on the page.

Ownership and control

People with significant control (PSCs) are people or organisations recorded as having significant control. This is not a complete shareholder list.

Inc. Spero Therapeutics

Company

Notification date: 13 Jun 2017

Share ownership

75–100%

Voting rights

75–100%

Director appointments

Can appoint and remove directors

Only control information supplied by the register is shown.

Additional PSC statements

The company says nobody has significant control.Notified 10 May 2017 · ceased 13 Jun 2017